|
|||||
|
|
Risk of cardiovascular mortality with androgen deprivation therapy in prostate cancer: A secondary analysis of the Prostate,Lung, Colorectal,and Ovarian (PLCO) Randomized Controlled Trial |
|
| Authors: | Santino S. Butler MD Brandon A. Mahal MD Javid J. Moslehi MD Anju Nohria MD Edward C. Dee BS Rishi Makkar BS Amanda Whitbeck BS Janet Wangoe BS Kent W. Mouw MD PhD Paul L. Nguyen MD Vinayak Muralidhar MD MSc |
| Affiliation: | 1. Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts;2. Division of Cardiovascular Medicine, Department of Vanderbilt University Medical Center, Nashville, Tennessee;3. Department of Cardiovascular Medicine, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts |
| Abstract: | |
| Keywords: | androgen deprivation therapy cardiovascular death comorbidity high-risk prostate cancer intermediate-risk prostate cancer prostate neoplasms |